PDE4D and achalasia-alacrima syndrome: Surprisingly, discrepant data has been recently published, reporting a significant increase in PDE4D expression in both human and experimental AAAs and that the specific deletion of PDE4D in VSMCs attenuates aneurysm formation in a mouse model [66].